drugset / Trial / NCT01723891

Study To Compare Safety and Pharmacokinetic Properties of Surfolase Capsule and HT-002-01 in Healthy Male Volunteers

NCT01723891 ↗

Phase 1 Completed 24 enrolled Hyundai Pharmaceutical Co., LTD.
RandomizedCrossoverOpen-labelTreatment

Summary

Study to compare safety and pharmacokinetic properties of surfolase capsule and HT-002-01 after oral administration for one day in healthy male volunteer.

Timeline

Start
2012-11
Primary completion
—
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Comparator AMBROXOL ACEFYLLINATE Small molecule — —
Comparator HT-002-01 Unknown — —

Indications

No indication recorded.